Nate Massari

Nate Massari has an extensive work experience spanning over two decades. Nate currently serves as the Chief Business Officer at Anjarium Biosciences since 2022. Prior to this, they worked as the Executive Vice President of Rare Disease Operations at Aytu BioPharma from 2021 to 2022. From 2019 to 2021, Nate was a Co-Founder at Rumpus Therapeutics. Before that, they held the position of Senior Vice President of Corporate Development & Strategy at AmerisourceBergen from 2014 to 2019. Nate also had roles at Endo Pharmaceuticals, MedImmune, Centocor, and Accenture, where they gained valuable experience in various leadership positions.

Nate Massari completed their Bachelor of Arts degree in History from Princeton University from 1996 to 2000. Following this, they pursued a Master of Business Administration degree in Marketing from The Wharton School from 2004 to 2006.